Skip to main content
Journal ArticleOPEN ACCESS

Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen

Haematologica (2007) 92(1) 139-140
DOI: 10.3324/haematol.10564
82Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

We report six cases of Pneumocystis jirovecii pneumonia (PCP) verified by immunoflourescence/polymerase chain reaction of bronchoalveolar fluid among 46 lymphoma patients (13%) who received rituximab-CHOEP-14 at our institution. PCP prophylaxis should be standard management for this group of patients and also considered for patients treated with rituximab-CHOP-14, CHOP-14 or CHOEP-14.

Cite

CITATION STYLE

APA

Kolstad, A., Holte, H., Fosså, A., Lauritzsen, G. F., Gaustad, P., & Torfoss, D. (2007). Pneumocystis jirovecii pneumonia in B-cell lymphoma patients treated with the rituximab-CHOEP-14 regimen. Haematologica, 92(1), 139–140. https://doi.org/10.3324/haematol.10564

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free